Jani Ahonala retweeted
COVID has transformed outpatient cancer care, driving an unprecedented adoption of telehealth. @theNCI intends to study what this means for patients. Send us your thoughts on the important research questions via our RFI grants.nih.gov/grants/guide/…
Jani Ahonala retweeted
Musings+of+a+Cancer+Doctor journals.lww.com/oncology-ti…. Some thoughts on the stories we tell and the lessons we learn in pandemics.
Jani Ahonala retweeted
Tämä kuuluu samaan kategoriaan, jossa joku oli todennut lähes kaikkien maailman arvokkaimpien internet-yhtiöiden olleen perustamisensa aikaan syystä tai toisesta laittomia Suomessa.
Enkä usko, että kyse on lainsäädännöstämme. Kyse on nuivasta asenteesta. hs.fi/talous/art-20000064250…
Jani Ahonala retweeted
Trump is trying to slash protections for more than 9 million acres of national parks.
Trees that are more than 1,000 years old will be razed.
These are the kinds of actions that can never be undone -- and it will barely make the news. salon.com/2019/12/15/forest-…
Jani Ahonala retweeted
Finland is governed by a coalition of five parties. All of them are now headed by women
Finland: A country run by women
Jani Ahonala retweeted
I’m humbled and hugely excited by the opportunity to lead @gatesfoundation as its next CEO. I’m eager to continue to work with my colleagues and our partners to help ensure everyone in the U.S. and around the world has the chance to lead a healthy, productive life.
Jani Ahonala retweeted
89% of audience responders at ASCO Quality Symposium agree that symptom monitoring with patient-reported outcomes would be beneficial in their oncology practice #ASCOQLTY19 #PRO – at San Diego, CA
Jani Ahonala retweeted
Lucky to have the team that supports me in everything I do 👌💪 and hope I can pay it forward in the years to come inventure.fi/inventure-appoi… #NordicMade #helsyes #STHLMTech #cphftw
Jani Ahonala retweeted
Tämä on mielestäni tärkeä, kansanvaltaa arvostava kädenojennus. Demokratia toimii sitä paremmin mitä useampi kokee olevansa mukana. Äänestysaktiivisuuden nosto on yhteinen asia. #vaalit #hsfi hs.fi/kotimaa/art-2000006053…
Jani Ahonala retweeted
@bmsnews to acquire Celgene to create a leading innovative biopharma company one.bms.com/2F6ibQU
Jani Ahonala retweeted
Laura Saarikoski kertoo olevansa maailman mittakaavassa mies. Onneksi me palasimme Suomeen.
hs.fi/ulkomaat/art-200000595…
Jani Ahonala retweeted
Hyvä päätös. Lääketiede on #tiede eli perustuu tutkittuun tietoon, ei #huuhaa'han. #terveys yle.fi/uutiset/3-10564561?ut…
Jani Ahonala retweeted
Lääkäri Antti Heikkilän uutuuskirja vilisee virheitä – HS pyysi asiantuntijoita arvioimaan tekstin: ”Tällaiset väitteet voivat johtaa kuolemantapauksiin”, professori sanoo hs.fi/sunnuntai/art-20000059…
Jani Ahonala retweeted
#SABCS18 My Stanford colleague Christina Curtis presents fascinating update of METABRIC genomic study, defining late recurrent ER pos pts at genomic level. Multiple integrative subgroups with specific drivers. This has potential therapy implications. Cool.
Jani Ahonala retweeted
Very insightful comments from Tom @VarianMedSys and Kathryn @CapricornVenture re @NoonaHealthcare opening @Frontiers2018
Jani Ahonala retweeted
Concern about side effects is strongest impetus for patients choosing whether to receive chemotherapy says @Hawleysaraht at @corp_UNC UNC Outcomes Breakfast... but we don’t yet widely collect patient-reported side effects in oncology trials with PRO-CTCAE nejm.org/doi/full/10.1056/NE… – at Chapel Hill, NC
Are you interested of the value and future of patient-reported outcomes in Oncology? Meet Noona team @myESMO 2018
Jani Ahonala retweeted
Combining Noona and Varian’s services offers a robust solution for patients to actively engage with their cancer care team during treatment, recovery and post-treatment ow.ly/WBbo30mfwec @NoonaHealthcare @VarianMedSys #Finland #healthtech #software #cancercare #acquisition






















